Wed, Sep 3, 2014, 4:28 AM EDT - U.S. Markets open in 5 hrs 2 mins

Recent

% | $
Quotes you view appear here for quick access.

Dynavax Technologies Corporation Message Board

outboard.jack 148 posts  |  Last Activity: 18 hours ago Member since: Nov 26, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    ITYS

    by outboard.jack Aug 31, 2014 10:15 PM
    outboard.jack outboard.jack 18 hours ago Flag

    ITYS
    Grey, I Told You So *

  • Reply to

    ITYS

    by outboard.jack Aug 31, 2014 10:15 PM
    outboard.jack outboard.jack 20 hours ago Flag

    Kia

    I'm a Perma-Bull
    The CODE was sent out by Grey with a 25K Buy
    With no SAE DVAX will start a steady move up soon
    The Shorts that are gonna cover are running Short on TIME
    And those wanting to get in or add are buying the "manipulated" dips
    Take a look at the daily historical prices from 
    Nov 1 011 Thru Nov 1 012, Leading up to our date with Daum.
    My best " Guess " OCT we start the move 
    You can Bet the Invested Institutions will AID the move  
    Just My Take, Think For Yourself *

  • outboard.jack by outboard.jack Aug 31, 2014 10:15 PM Flag

    25k @1.49 is CODE Not investment
    Heads up YOU Listening ?
    Grey is talking to ya
    As Rave said he's sucking you in, Or he's telling you the water is fine
    Sellers are the Short mans Tool at this point
    Same trade over and over
    Good luck and as always don't listen to anything I have to say Think for yourself!

  • outboard.jack by outboard.jack Aug 29, 2014 4:13 PM Flag

    WOO-HOO *

  • Reply to

    Sentiment

    by nokia700 Aug 27, 2014 3:07 PM
    outboard.jack outboard.jack Aug 27, 2014 7:57 PM Flag

    I'll put two pennies in the POT of Sentiment
    Every time our little stock starts an upward move it's put back in it's place with true, accurate guidance. You can bet no one want's less for their shares, 27 million shares are short how many of these do you think are retail? I would guess no more than 10% 
    OCT Options are a good tell*

  • outboard.jack by outboard.jack Aug 27, 2014 7:30 PM Flag

    BERKELEY, CA--(Marketwired - Mar 3, 2014) - Dynavax Technologies Corp. (NASDAQ: DVAX) today announced a $5.4 million milestone payment from its collaborator, AstraZeneca. The companies also amended their research collaboration and license agreement to transfer responsibility for conduct of further clinical trials from Dynavax to AstraZeneca, following completion of the ongoing Phase 1 clinical study of AZD1419 for the treatment of asthma.

    In October 2013 dosing began in a Phase 1 study to assess the safety of inhaled doses of AZD1419 in up to 45 healthy subjects, to be followed by up to 24 patients with mild asthma. Remaining potential milestone payments to Dynavax total approximately $100 million. In addition, Dynavax will receive royalties on worldwide sales of any approved products and will have the opportunity to co-promote in the United States.

    AstraZeneca

    Looking like Data from AZD1419 is Promising enough for AstraZeneca to take it through Phase III study.
     Potentially Dynavax could see More Milestone payments  Pre Hep-Lisa-V Phase III
    Conclusion. 
    Another Multiple to our over all  Market Value

    The companies also amended their research collaboration and license agreement to  ( transfer responsibility ) for conduct of further clinical trials from Dynavax to AstraZeneca.

    ( Royalties ) on worldwide sales of any approved products 

    Remaining potential milestone payments to Dynavax total approximately
    ( $100 million )

  • Reply to

    buying oppurtunity?

    by kentwu28 Aug 27, 2014 11:19 AM
    outboard.jack outboard.jack Aug 27, 2014 11:34 AM Flag

    Didn't take you very long
    Woo Hoo, LOL *

  • Reply to

    Time for another reality check....

    by jdoobie00 Aug 26, 2014 1:56 AM
    outboard.jack outboard.jack Aug 27, 2014 7:32 AM Flag

    Doob

    "While seeking Rave-enge, dig two graves - one for yourself"

    This was my thoughts on the RAVE and his transformation 
    I'm OK with his Rave against the Machine as it's No different 
    Than Me having nothing but the Opposite point of view and 
    Posting to the like. 

    Rave thinks we are all digging our own graves 
    And it has yep to play out

    "We reside in the same Hole But that's not for All to Judge*

    This is just a play on words, Rave has chosen to wear his sack on the outside of his shorts for all to scrutinize 

  • Reply to

    Time for another reality check....

    by jdoobie00 Aug 26, 2014 1:56 AM
    outboard.jack outboard.jack Aug 26, 2014 7:50 AM Flag

    While seeking Rave-enge, dig two graves - one for yourself.

    See what I did there, LOL

    We reside in the same Hole But that's not for All to Judge*

  • Reply to

    THIS #$%$ CAT!

    by strawhatjoe Aug 22, 2014 11:33 AM
    outboard.jack outboard.jack Aug 22, 2014 4:23 PM Flag

    LOL *

  • Reply to

    The best way to beat the cancer......

    by theblackraven08 Aug 22, 2014 10:32 AM
    outboard.jack outboard.jack Aug 22, 2014 10:43 AM Flag

    Good Morning*

  • Reply to

    $1.40

    by kentwu28 Aug 19, 2014 11:52 AM
    outboard.jack outboard.jack Aug 20, 2014 12:38 PM Flag

    WOO,
    We have some historical PPS with two other phase III studies.
    Will all of the same risk you have listed you might want to do some DD.

  • Reply to

    ensuthiasm!

    by kentwu28 Aug 19, 2014 4:09 PM
    outboard.jack outboard.jack Aug 20, 2014 9:34 AM Flag

    SPELLCHECK!

  • 08/07/14
    Dynavax and its collaboration partner, AstraZeneca, are evaluating protocols for a clinical trial in patients with asthma.

    Dynavax.  entered into a research collaboration and license agreement with AstraZeneca for the discovery and development of TLR9 agonist-based therapies for the treatment of asthma and chronic obstructive pulmonary disease. The agreement was amended in Oct 2011 wherein Dynavax was responsible for initial development of AZD1419.
    Dynavax and AstraZeneca have now further amended their research collaboration and license agreement. As per the amended agreement, AstraZeneca is now responsible for further clinical trials following the completion of the ongoing phase I clinical study on asthma candidate AZD1419.
    Dynavax completed a phase I study conducted to assess the safety of inhaled doses of AZD1419 in up to 45 healthy subjects which will then be followed by up to 24 patients suffering from mild asthma.
     Dynavax is entitled to potential milestone payments of approximately $100 million. In addition, the company will receive royalties on sales of any approved products globally along with an opportunity to co-promote in the U.S

    Commercial Opportunity 

    According to the World Health Organization, asthma affects 300 million people worldwide. Asthma is a chronic disease of the lungs and is caused primarily by allergic inflammation of the airways. In addition, 210 million people worldwide are affected by COPD, a term used to describe chronic lung diseases that limit airflow in the lungs. Analysts estimate the current worldwide market opportunity for asthma and COPD therapies to be over $15 billion annually.

    On Watch*

  • Reply to

    ensuthiasm!

    by kentwu28 Aug 19, 2014 4:09 PM
    outboard.jack outboard.jack Aug 19, 2014 4:16 PM Flag

    Its great action here
    One of the best trading Bio stocks out there
    Fish in a bowl WOO *
    That 1.25 call is a bit stale my BOY *

  • Reply to

    Clueless

    by outboard.jack Aug 19, 2014 8:55 AM
    outboard.jack outboard.jack Aug 19, 2014 11:33 AM Flag

    Clearly out of water *

  • outboard.jack by outboard.jack Aug 19, 2014 8:55 AM Flag

    Clear case of Slander and defamation suit being built by Aq8mar
    Just saying *

  • Reply to

    Watch 60 Minutes tonight.......

    by theblackraven08 Aug 17, 2014 10:07 AM
    outboard.jack outboard.jack Aug 17, 2014 5:11 PM Flag

    Rigged?
    Who doesn't know it's rigged ?
    For me it's a Game like in Casino
    Dispite being rigged even the house needs the market to rise and fall to make it work.
    So the Game is to figure out the timing and like in any game your gonna loose it's part of learning the action.
    And it's understandable that one would get MAD if they lost just as one would get Happy if they WON*
    Your not gonna start using any (T urd) references are ya?

  • outboard.jack outboard.jack Aug 17, 2014 4:59 PM Flag

    Hepatitis B Vaccine Market to Experience Modest Growth Despite Upcoming Product Launches, says GlobalData

    Hepatitis B Vaccine Market to Experience Modest Growth Despite Upcoming Product Launches, says GlobalData

    LONDON, UK (GlobalData), 11 February 2014 - The global hepatitis B virus (HBV) vaccine market value will experience modest growth over the coming years, climbing from approximately $959.9 million in 2012 to $1.19 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 2.2%, according to a new report from research and consulting GlobalData.

    The company's latest report* states that out of the eight major markets — the US, Canada, France, Germany, Italy, Spain, the UK and Japan — the majority of HBV vaccine sales will take place in the US, which will boast a higher CAGR of 3.4% and expand its market share from 55% to 61.7% during the forecast period. The US will be followed by Canada and the five European countries, with expected CAGRs of 1% and 0.5%, respectively.

    Christopher Pace, Ph.D., GlobalData's Analyst covering Infectious Diseases, says: "Dynavax hopes to leverage Heplisav's superior immunogenicity and dosing regimen to increase HBV vaccine uptake in the adult market. On the other hand, Sanofi Pasteur MSD is positioning Hexyon to be the first fully liquid pediatric hexavalent vaccine."

    However, GlobalData believes that inadequate HBV vaccination coverage rates in certain high-risk populations represents one of the most important unmet needs in the marketplace.

    Pace says: "In the pediatric segment, companies are leveraging combination vaccines to increase HBV vaccine uptake, while improved dosing regimens are necessary to increase vaccination coverage rates in adults.

    More

  • outboard.jack outboard.jack Aug 15, 2014 5:29 PM Flag

    Wulf
    Thanks,
    I will check it out over the weekend
    But you do know we have world rights for Hep-Lisa -V
    You dont think outside US is only good for 100M Right?

DVAX
1.40-0.02(-1.41%)Sep 2 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.